Your browser doesn't support javascript.
loading
41-Week Study of Progressive Diabetic Nephropathy in the ZSF1 fa/faCP Rat Model.
Homer, Bruce L; Dower, Ken.
Afiliação
  • Homer BL; 1 Drug Safety, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
  • Dower K; 2 Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
Toxicol Pathol ; 46(8): 976-977, 2018 12.
Article em En | MEDLINE | ID: mdl-30278832
This symposium synopsis summarizes key results from a 41-week study of diabetic nephropathy (DN) in the type 2 diabetic ZSF1 fa/faCP rat model. During this study, we conducted longitudinal analysis of biomarkers, renal histopathology, ultrastructural assessment, renal quantitative image analysis, and transcriptome analysis of glomerular-enriched tissue. We concluded that there is translational value for using the ZSF1 rat model in mechanistic and therapeutic intervention efficacy studies for type 2 DN.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Modelos Animais de Doenças Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Modelos Animais de Doenças Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article